Quest Diagnostics (DGX) Accounts Payables (2009 - 2026)

Quest Diagnostics has disclosed Accounts Payables across 18 years of filings, most recently posting $1.5 billion for Q1 2026.

• Accounts Payables for Q1 2026 came in at $1.5 billion, up 18.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 18.39% YoY), and the FY2025 annual result was $1.6 billion, up 14.78% from the prior year.
• Accounts Payables came in at $1.5 billion for Q1 2026 at Quest Diagnostics, down from $1.6 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.6 billion in Q4 2025 to a low of $1.2 billion in Q3 2023.
• The 5-year median for Accounts Payables is $1.4 billion (2023), against an average of $1.4 billion.
• Across the five-year window, Accounts Payables fell 22.41% in 2023 and gained 18.39% in 2026, its largest moves.
• Quest Diagnostics' Accounts Payables stood at $1.4 billion in 2022, then retreated by 2.65% to $1.4 billion in 2023, then advanced by 2.58% to $1.4 billion in 2024, then climbed by 14.78% to $1.6 billion in 2025, then decreased by 6.25% to $1.5 billion in 2026.
• The last three Accounts Payables figures came in at $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.